Mother to child transmission of hepatitis C virus: A case-control study of risk factors

2001 ◽  
Vol 120 (5) ◽  
pp. A366 ◽  
Author(s):  
Sophie Poiraud ◽  
Hosp Tenon ◽  
Joseph Cohen ◽  
Xavier Amiot ◽  
Nadia Berkane ◽  
...  
2001 ◽  
Vol 120 (5) ◽  
pp. A366-A366 ◽  
Author(s):  
S POIRAUD ◽  
H TENON ◽  
J COHEN ◽  
X AMIOT ◽  
N BERKANE ◽  
...  

2010 ◽  
Vol 7 (1) ◽  
Author(s):  
Kerina Duri ◽  
Felicity Z Gumbo ◽  
Knut I Kristiansen ◽  
Nyaradzi E Kurewa ◽  
Munyaradzi P Mapingure ◽  
...  

1994 ◽  
Vol 112 (3) ◽  
pp. 595-601 ◽  
Author(s):  
K. R. Neal ◽  
D. A. Jones ◽  
D. Killey ◽  
V. James

SUMMARYThe introduction of screening for hepatitis C virus (HCV) by the National Blood Transfusion Service identified donors who had acquired HCV infection. We undertook a case-control study amongst blood donors in the Trent Region to determine risks for HCV infection. A total of 74 blood donors confirmed positive for hepatitis C infection and 150 age, sex and donor venue matched controls were included in the study. Fifty-three percent of hepatitis C infected blood donors reported previous use of injected drugs compared to no controls; relative risk (RR) not estimatable (lower limit 95% CI = 20). Other risk factors were a history of: receipt of a blood transfusion or blood products RR = 3·6 (95% CI 1·5–8·3), having been a ‘health care worker’ RR = 2·8 (95% CI 1·1–7·6), tattooing RR = 3·3 (95% CI 1·2–8·7), and an association with having been born abroad RR = 3·2 (95% CI 1·1–9·5). No risk was shown for a history of multiple sexual partners, ear piercing or acupuncture. Injecting drug use explains more than 50% of hepatitis C infections in blood donors, a group who are less likely to have injected drugs than the general population.


1999 ◽  
Vol 116 (4) ◽  
pp. 893-899 ◽  
Author(s):  
Gilles Delage ◽  
Claire Infante–Rivard ◽  
Jo–Anne Chiavetta ◽  
Bernard Willems ◽  
David Pi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document